AB-16B5 / Alethia BioTherap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AB-16B5 / Alethia BioTherap
NCT04364620: AB-16B5 Combined With Docetaxel in Subjects With Metastatic Non-Small Cell Lung Cancer (EGIA-002)

Recruiting
2
40
Canada, US
AB-16B5, Docetaxel
Alethia Biotherapeutics
NSCLC Stage IV
02/22
07/22

Download Options